Enveric Biosciences Files 8-K on Financials
Ticker: ENVB · Form: 8-K · Filed: Aug 14, 2025 · CIK: 890821
| Field | Detail |
|---|---|
| Company | Enveric Biosciences, Inc. (ENVB) |
| Form Type | 8-K |
| Filed Date | Aug 14, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Enveric Biosciences dropped an 8-K detailing its financial results. Check it out.
AI Summary
Enveric Biosciences, Inc. filed an 8-K on August 14, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located in Naples, Florida.
Why It Matters
This filing provides investors with an update on Enveric Biosciences' financial performance and condition, which is crucial for assessing the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing of financial results and does not indicate any immediate or significant risks.
Key Players & Entities
- Enveric Biosciences, Inc. (company) — Registrant
- 0001641172-25-023724 (filing_id) — Accession Number
- August 14, 2025 (date) — Date of Report
- Naples, FL (location) — Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K report filed?
The report was filed on August 14, 2025.
What is the exact name of the company filing this report?
The exact name of the registrant is Enveric Biosciences, Inc.
Where are Enveric Biosciences' principal executive offices located?
The principal executive offices are located at 4851 Tamiami Trail N, Suite 200, Naples, FL 34103.
What is the Commission File Number for Enveric Biosciences?
The Commission File Number is 001-38286.
Filing Stats: 540 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2025-08-14 08:00:37
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share ENVB The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 39KB
- ex99-1_001.jpg (GRAPHIC) — 9KB
- 0001641172-25-023724.txt ( ) — 261KB
- envb-20250814.xsd (EX-101.SCH) — 3KB
- envb-20250814_lab.xml (EX-101.LAB) — 33KB
- envb-20250814_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 14, 2025 ENVERIC BIOSCIENCES, INC. By: /s/ Joseph Tucker Joseph Tucker, Ph.D. Chief Executive Officer